{
    "title": "US FDA puts Gilead Sciences blood cancer drug studies on hold",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12428993/US-FDA-puts-Gilead-Sciences-blood-cancer-drug-studies-hold.html",
    "date": "2023-08-21",
    "keywords": [
        "company",
        "drug",
        "magrolimab",
        "treatment",
        "monday",
        "health",
        "regulator",
        "hold",
        "blood",
        "cancer",
        "month",
        "latestage",
        "trial",
        "access",
        "buyout",
        "inc",
        "march",
        "food",
        "administration",
        "fda",
        "screening",
        "enrollment",
        "study",
        "impact",
        "action",
        "combination",
        "type",
        "chemotherapy",
        "azacitidine",
        "risk",
        "group",
        "bone",
        "marrow",
        "failure",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "shilpi",
        "majumdar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}